Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Deals
Manufacturing
HHS taps Marinus Pharma to produce API for anti-seizure drug
The U.S. government has exercised a $12.3 million option with Marinus Pharmaceuticals to manufacture the API integral to its anti-seizure drug.
Joseph Keenan
Sep 22, 2022 9:40am
Valneva, IDT Biologika end COVID vaccine deal as demand slides
Sep 20, 2022 9:10am
Lonza, Touchlight partner on 'doggybone DNA' development
Sep 6, 2022 9:05am
Amgen bided its time to snatch up ChemoCentryx
Sep 1, 2022 10:55am
Bayer's BlueRock inks cardiovascular cell therapy delivery deal
Aug 30, 2022 11:38am
Merck-Seagen merger stalled over price: Bloomberg
Aug 26, 2022 9:45am
